ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

A Pilot Study of BMS-512148 in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00357370

Public ClinicalTrials.gov record NCT00357370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pilot Study of the Efficacy and Safety of BMS-512148 on Glycemic Control in Subjects With Type 2 Diabetes Treated Aggressively But Not Controlled on Combination Antihyperglycemic Therapy With Metformin and/or Thiazolidinedione (TZD) and Insulin.

Study identification

NCT ID
NCT00357370
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
163 participants

Conditions and interventions

Interventions

  • Dapagliflozin Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Feb 29, 2008
Completion
Feb 29, 2008
Last update posted
May 10, 2017

2006 – 2008

United States locations

U.S. sites
16
U.S. states
14
U.S. cities
16
Facility City State ZIP Site status
Nea Clinic Jonesboro Arkansas 72401
Valley Research Fresno California 93720
Bernstein, Richard Greenbrae California 94904
Jacksonville Center For Clinical Research Jacksonville Florida 32205
Endocrine Research Solutions, Inc. Roswell Georgia 30076
Indiana University Indianapolis Indiana 46202
Model Clinical Research Llc Baltimore Maryland 21204
University Of Michigan Ann Arbor Michigan 48109
St. Louis Center For Clinical Research St Louis Missouri 63128
Suny Upstate Medical University Syracuse New York 13210
Mountain Diabetes And Endocrine Center Asheville North Carolina 28801
Your Diabetes Endocrine Nutrition Group Mentor Ohio 44060
Research Institute Of Dallas, P.A. Dallas Texas 75231
Diabetes And Glandular Disease Research Associates, P.A. San Antonio Texas 78229
Rainier Clinical Research Center Renton Washington 98055
Advanced Healthcare S.C. Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00357370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 10, 2017 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00357370 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →